International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 112 | Views: 179

Research Paper | Medicine Science | Iraq | Volume 3 Issue 9, September 2014


Synthesis of Selenocystine Complex for Medicine Application

Waleed A. Mahmoud [3] | Fadhil M. Abid | Zahraa A. Mahdi


Abstract: The selenocystine complex was biologically prepared by using local yeast; the prepared complex was characterized by using appropriate physical measurement i. e. FAAS, FTIR spectroscopy and melting point and analyzed by reversed phase HPLC and was compared with authentic standard. To treatment the deficiency level of selenium in hypertension and myocardial infarction patients, the complex was formulated at estate of drug and medical appliance in Sammara (in Iraq) as tablets. The present study involved the following groups: 1-100 healthy volunteers (55 men, 45women), 2-50 patients with myocardial infarction (men) and 3-50 patients with hypertension (men). The concentration of selenium was determined in the blood serum of healthy and patients volunteers by using graphite furnace atomic absorption. The results showed that patients with hypertension and myocardial infarction had lower concentration of selenium in blood serum as compared with the healthy group. We supplied (20) patients with myocardial infarction and (20) patients with hypertension with (200mg) selenocystine complex tablet for three months. The results showed the selenium concentration in blood serum of hypertension patients were elevated from (42-53ng/ml) to (71-63ng/ml) and for myocardial infarction patients, the concentration were elevated from (35-45ng/ml) to (72-66ng/ml).


Keywords: Synthesis, Complex, Medicine, Yeast


Edition: Volume 3 Issue 9, September 2014,


Pages: 1036 - 1041


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top